Bioreactors News and Research

RSS
CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

CEVEC, Pevion Biotech sign license option agreement for transient CAP-T cell expression technology

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Genzyme's Lumizyme for Pompe disease receives FDA marketing approval

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Alnylam Biotherapeutics presents new data on RNAi technologies at Cell Culture Engineering XII

Sartorius Group's first-quarter consolidated sales revenue increases by 3.0% to 150.4 million euros

Sartorius Group's first-quarter consolidated sales revenue increases by 3.0% to 150.4 million euros

Avid Bioservices highlights data of single-use bioreactors and traditional stainless steel bioreactors

Avid Bioservices highlights data of single-use bioreactors and traditional stainless steel bioreactors

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Growing human therapeutic proteins in algae can help reduce cancer treatment cost

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Humacyte, Xcellerex collaborate to develop novel vascular graft for transplantation technologies

Shire receives FDA Fast Track designation for REPLAGAL

Shire receives FDA Fast Track designation for REPLAGAL

Cantimer, Advanced Instruments announce license and product development agreement

Cantimer, Advanced Instruments announce license and product development agreement

TAP to showcase ambr system at Cell Line Development and Engineering 2010

TAP to showcase ambr system at Cell Line Development and Engineering 2010

TAP and EPSRC Centre for Innovative Manufacturing in Regenerative Medicine continue collaboration

TAP and EPSRC Centre for Innovative Manufacturing in Regenerative Medicine continue collaboration

Pall acquires U.S. biotechnology company

Pall acquires U.S. biotechnology company

Alternative, fast and safe process for producing large quantities of effective flu vaccines

Alternative, fast and safe process for producing large quantities of effective flu vaccines

The Automation Partnership's ambr technology to be previewed at the Bioprocess International Conference

The Automation Partnership's ambr technology to be previewed at the Bioprocess International Conference

SAFC Pharma expands contract manufacturing services

SAFC Pharma expands contract manufacturing services

NIH grants $5 million to Pittsburgh researchers

NIH grants $5 million to Pittsburgh researchers

Update on Cerezyme and Fabrazyme supply from Genzyme Corporation

Update on Cerezyme and Fabrazyme supply from Genzyme Corporation

Genzyme updates on Cerezyme supply plus 2009 financials

Genzyme updates on Cerezyme supply plus 2009 financials

Bioprocess increases vaccine yield

Bioprocess increases vaccine yield

SAFC Pharma augments assay development capabilities

SAFC Pharma augments assay development capabilities